Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
16-demethylrifamycin W + NAD(P)H + O2
? + NAD(P)+ + H2O
rifampicin + NAD(P)H + O2
2'-N-hydroxyrifampicin + NAD(P)+ + H2O
rifamycin SV + NAD(P)H + O2
? + NAD(P)+ + H2O
additional information
?
-
16-demethylrifamycin W + NAD(P)H + O2
? + NAD(P)+ + H2O
-
Substrates: -
Products: -
?
16-demethylrifamycin W + NAD(P)H + O2
? + NAD(P)+ + H2O
-
Substrates: -
Products: -
?
16-demethylrifamycin W + NAD(P)H + O2
? + NAD(P)+ + H2O
-
Substrates: -
Products: -
?
rifampicin + NAD(P)H + O2
2'-N-hydroxyrifampicin + NAD(P)+ + H2O
-
Substrates: -
Products: -
?
rifampicin + NAD(P)H + O2
2'-N-hydroxyrifampicin + NAD(P)+ + H2O
Substrates: -
Products: -
?
rifampicin + NAD(P)H + O2
2'-N-hydroxyrifampicin + NAD(P)+ + H2O
-
Substrates: -
Products: -
?
rifampicin + NAD(P)H + O2
2'-N-hydroxyrifampicin + NAD(P)+ + H2O
Substrates: -
Products: -
?
rifamycin SV + NAD(P)H + O2
? + NAD(P)+ + H2O
-
Substrates: -
Products: -
?
rifamycin SV + NAD(P)H + O2
? + NAD(P)+ + H2O
-
Substrates: -
Products: -
?
rifamycin SV + NAD(P)H + O2
? + NAD(P)+ + H2O
-
Substrates: -
Products: -
?
rifamycin SV + NAD(P)H + O2
? + NAD(P)+ + H2O
-
Substrates: -
Products: -
?
rifamycin SV + NAD(P)H + O2
? + NAD(P)+ + H2O
-
Substrates: -
Products: -
?
additional information
?
-
Substrates: the enzyme from Rhodococcus equi has the ability to inactivate the antibiotic rifampicin via its decomposition and confers low-level rifampin resistance
Products: -
?
additional information
?
-
Substrates: the enzyme from Rhodococcus equi has the ability to inactivate the antibiotic rifampicin via its decomposition and confers low-level rifampin resistance
Products: -
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
rifampicin + NAD(P)H + O2
2'-N-hydroxyrifampicin + NAD(P)+ + H2O
additional information
?
-
rifampicin + NAD(P)H + O2
2'-N-hydroxyrifampicin + NAD(P)+ + H2O
-
Substrates: -
Products: -
?
rifampicin + NAD(P)H + O2
2'-N-hydroxyrifampicin + NAD(P)+ + H2O
-
Substrates: -
Products: -
?
additional information
?
-
Substrates: the enzyme from Rhodococcus equi has the ability to inactivate the antibiotic rifampicin via its decomposition and confers low-level rifampin resistance
Products: -
?
additional information
?
-
Substrates: the enzyme from Rhodococcus equi has the ability to inactivate the antibiotic rifampicin via its decomposition and confers low-level rifampin resistance
Products: -
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
metabolism
RIFMO catalyzes the hydroxylation of rifampicin at the C2 atom followed by cleavage of the ansa linkage, which leads to inactivation of the antibiotic by preventing key contacts with the RNA polymerase target
metabolism
-
RIFMO catalyzes the hydroxylation of rifampicin at the C2 atom followed by cleavage of the ansa linkage, which leads to inactivation of the antibiotic by preventing key contacts with the RNA polymerase target
-
physiological function
the enzyme from Rhodococcus equi has the ability to inactivate the antibiotic rifampicin via its decomposition and confers low-level rifampin resistance
physiological function
-
the rox gene is capable of initiating rifampicin degradation with another metabolite formation at the first step and having a role as the secondary rifampicin resistance factor in Nocardia farcinica
physiological function
-
the rox gene is capable of initiating rifampicin degradation with another metabolite formation at the first step and having a role as the secondary rifampicin resistance factor in Nocardia farcinica
-
physiological function
-
the enzyme from Rhodococcus equi has the ability to inactivate the antibiotic rifampicin via its decomposition and confers low-level rifampin resistance
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
in complex with rifampicin, to 1.8 A resolution. RifMO is a class A flavoprotein monooxygenase and is similar in fold and quaternary structure to MtmOIV and OxyS, in the mithramycin and oxytetracycline biosynthetic pathways, respectively. RifMO dimerizes via the FAD-binding domain to form a bell-shaped homodimer in solution with a maximal dimension of 110 A. The rifampicin naphthoquinone blocks access to the FAD N5 atom
structure of RIFMO in complex with the hydroxylated rifampicin product, to 2.10 A resolution. Structure shows a breach of the ansa aliphatic chain of rifampicin between naphthoquinone C2 and amide N1
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
additional information
-
the rox gene deletion mutation DELTArox gives no significant influence to the rifampicin resistance of Nocardia farcinica. Transformation with plasmid pKNL027_N05 overexpressing the rox gene markedly raises the rifampicin resistance in the strain with the deletion mutation of the rpoB2 gene as the principal rifampicin resistance determinant. Rifampicin is degraded by the wild-type strain, whereas it remains intact when incubated with the DELTArox strain
additional information
-
the rox gene deletion mutation DELTArox gives no significant influence to the rifampicin resistance of Nocardia farcinica. Transformation with plasmid pKNL027_N05 overexpressing the rox gene markedly raises the rifampicin resistance in the strain with the deletion mutation of the rpoB2 gene as the principal rifampicin resistance determinant. Rifampicin is degraded by the wild-type strain, whereas it remains intact when incubated with the DELTArox strain
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
expression in Escherichia coli
gene iri, DNA and amino acid sequence determination and analysis, recombinant expression, the gene cloned from the Rhodococcus equi strain ATCC 14887 confers a 10fold increase in resistance to rifampin in Escherichia coli as well as a 25fold increase in Rhodococcus
gene rox, cloning and expression of wild-type and mutant enzymes in Escherichia coli strains JM109 and BL21(DE3)
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Hoshino, Y.;, Fujii, S., Shinonaga, H.; Arai, K.; Saito, F.; Fukai, T.; Satoh, H.; Miyazaki, Y.; Ishikawa, J.
Monooxygenation of rifampicin catalyzed by the rox gene product of Nocardia farcinica: structure elucidation, gene identification and role in drug resistance
J. Antibiot.
63
23-28
2010
Nocardia farcinica, Nocardia farcinica IFM 10152
brenda
Andersen, S.; Quan, S.; Gowan, B.; Dabbs, E.
Monooxygenase-like sequence of a Rhodococcus equi gene conferring increased resistance to rifampin by inactivating this antibiotic
Antimicrob. Agents Chemother.
41
218-221
1997
Rhodococcus equi (P95598), Rhodococcus equi ATCC 14887 (P95598)
brenda
Liu, L.K.; Abdelwahab, H.; Martin Del Campo, J.S.; Mehra-Chaudhary, R.; Sobrado, P.; Tanner, J.J.
The structure of the antibiotic deactivating, N-hydroxylating rifampicin monooxygenase
J. Biol. Chem.
291
21553-21562
2016
Nocardia farcinica (Q5YTV5), Nocardia farcinica, Nocardia farcinica IFM 10152 (Q5YTV5)
brenda
Liu, L.K.; Dai, Y.; Abdelwahab, H.; Sobrado, P.; Tanner, J.J.
Structural evidence for rifampicin monooxygenase inactivating rifampicin by cleaving its ansa-bridge
Biochemistry
57
2065-2068
2018
Nocardia farcinica (Q5YTV5), Nocardia farcinica IFM 10152 (Q5YTV5)
brenda
Zheng, X.; Liu, X.; Peng, S.; Zhou, Q.; Xu, B.; Yuan, H.; Tang, G.
Characterization of the rifamycin-degrading monooxygenase from rifamycin producers implicating its involvement in saliniketal biosynthesis
Front. Microbiol.
11
971
2020
Amycolatopsis mediterranei, Micromonospora sp. TP-A0468, Nocardioides dokdonensis, Salinispora arenicola, Streptomyces sp. TP-A0356
brenda